1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-5732
  5. NDC Package Code: 0093-5732-01 Oxycodone Hydrochloride

NDC Package 0093-5732-01 Oxycodone Hydrochloride

Tablet, Film Coated, Extended Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-5732-01
Package Description:
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code:
0093-5732
Proprietary Name:
Oxycodone Hydrochloride
Non-Proprietary Name:
Oxycodone Hydrochloride
Substance Name:
Oxycodone Hydrochloride
Usage Information:
OXYCODONE HCl EXTENDED-RELEASE TABLETS are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in:•Adults; and•Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent.Limitations of Use•Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1)], reserve OXYCODONE HCl EXTENDED-RELEASE TABLETS for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.•OXYCODONE HCl EXTENDED-RELEASE TABLETS are not indicated as an as-needed (prn) analgesic.
11-Digit NDC Billing Format:
00093573201
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
100 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1860129 - oxyCODONE HCl 20 MG 12HR Extended Release Oral Tablet, Abuse-Deterrent
  • RxCUI: 1860129 - Abuse-Deterrent 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet
  • RxCUI: 1860129 - oxycodone HCl 20 MG 12 HR Extended Release Oral Tablet, Abuse-Deterrent
  • RxCUI: 1860137 - oxyCODONE HCl 40 MG 12HR Extended Release Oral Tablet, Abuse-Deterrent
  • RxCUI: 1860137 - Abuse-Deterrent 12 HR oxycodone hydrochloride 40 MG Extended Release Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • OXYCODONE HYDROCHLORIDE 20 mg/1
    • Pharmacologic Class(es):
  • Full Opioid Agonists - [MoA] (Mechanism of Action)
  • Opioid Agonist - [EPC] (Established Pharmacologic Class)
    • DEA Schedule:
    Schedule II (CII) Substances
    Sample Package:
    No
    FDA Application Number:
    NDA022272
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    10-12-2015
    End Marketing Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0093-5732-01?

    The NDC Packaged Code 0093-5732-01 is assigned to a package of 100 tablet, film coated, extended release in 1 bottle of Oxycodone Hydrochloride, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet, film coated, extended release and is administered via oral form.

    Is NDC 0093-5732 included in the NDC Directory?

    Yes, Oxycodone Hydrochloride with product code 0093-5732 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on October 12, 2015.

    What is the NDC billing unit for package 0093-5732-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 100.

    What is the 11-digit format for NDC 0093-5732-01?

    The 11-digit format is 00093573201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20093-5732-015-4-200093-5732-01